CD4 and cancer: This can be shown by how Th17 and Tregs CD4 + T cell phenotypes play a central role in cancer, and how to the conditions within the tumor microenvironment (TME) can lead to a deregulation and hijacking of these T cell networks for tumor proliferation (Guéry and Hugues, 2015).